Developmental Origins of Chronic Lung Diseases. Mechanical Stretch, Micro-RNAs, and Hydrogels.

The primary function of the lungs is to exchange oxygen with carbon dioxide between the external environment and the internal cardiovascular system. Although seemingly straightforward, the development of a fully functional lung is fraught with challenges. To successfully undergo growth and maturation, the lungs develop through five well-orchestrated stages (2). Despite extensive work over the past decades, mechanisms through which mechanical forces contribute to epithelial differentiation and alveologenesis remain incompletely understood. Using mouse genetics, live imaging, and quantitative cell biology, Li and colleagues (1) demonstrated that mechanical forces act synergistically with local growth factors to drive alveolar epithelial cell differentiation. By aspirating amniotic fluid from mouse embryo yolk sacs, creating a condition of “oligoamnios,” the authors found that mechanical forces generated by inhalation of amniotic fluid are essential for alveolar epithelial type 1 (AT1) cell differentiation. When compared with lungs from littermate controls at Embryonic Day 18.5, terminal sac opening and cell shape flattening of AT1 cells were impaired in oligoamnios-treated embryos as assessed by immunostaining and time-sequenced imaging. The lack of AT1 differentiation was accompanied by a compensatory increase in AT2 epithelial cells, suggesting that mechanical stretch has less impact on AT2 cell differentiation than on AT1 cells. Secondarily, the authors explored cellular processes associated with saccular dilation and epithelial cell differentiation. Interestingly, the authors observed basal protrusions from cuboidal-shaped airway tip cells before alveolar formation. These cellular protrusions were actin based and extended into the adjacent mesenchyme. Over time, epithelial cells with basal protrusions constricted, as assessed by phosphorylated nonmuscle myosin light chain II, remained cuboidal in shape, and ultimately differentiated into AT2. Conversely, cells without basal protrusions became thinner and flattened over time, and differentiated into AT1 cells. To examine the mechanism underlying the development of these basal protrusions, the investigators used genetic mice and chemical inhibitors of fibroblast growth factor (FGF) 10. In the heterozygous FGF10 embryos or after chemical FGF10 inhibition in wild-type embryos, the number of progenitor cells with protrusions decreased, suggesting that protrusion and its associated mesenchymal connection were FGF10 dependent. These findings have significant clinical implications for children with developmental or chronic lung disease after preterm birth. Oligohydramnios and insufficient lung stretch contribute to pulmonary hypoplasia, especially in the setting of prolonged premature rupture of membranes before preterm birth and with diverse congenitalmalformations as omphaloceles and congenital diaphragmatic hernia, at least partly due to the lack of mechanical force–induced stimulation of AT1 cell differentiation (3, 4). For some fetuses with congenital diaphragmatic hernia, an in utero procedure, called fetoscopic endotracheal occlusion, is used to obstruct the trachea with a latex balloon (5). By occluding the trachea, airway-distending pressures are increased owing to ongoing epithelial production of lung liquid, which stretches the distal lung and stimulates AT1 and AT2 cell maturation (4). The fetoscopic endotracheal occlusion procedure likely improves survival through forced lung maturation by mechanical stretch (5), as suggested by this study. Despite the significant advances made by Li and colleagues (1), interrogating the effect of mechanical forces on other essential cells in lung development, specifically stromal and endothelial cells

[1]  N. Yi,et al.  Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants. , 2018, JCI insight.

[2]  Z. Wang,et al.  The Strength of Mechanical Forces Determines the Differentiation of Alveolar Epithelial Cells. , 2018, Developmental cell.

[3]  W. Göpel,et al.  Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development , 2017, The Journal of pediatrics.

[4]  A. Harris,et al.  The role of microRNAs in chronic respiratory disease: recent insights , 2017, Biological chemistry.

[5]  N. Ambalavanan,et al.  Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs , 2017, Nature Communications.

[6]  S. Carmichael,et al.  Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability , 2017, Nature materials.

[7]  A. Peacock,et al.  Pulmonary vascular and cardiac impairment in interstitial lung disease , 2017, European Respiratory Review.

[8]  J. Deprest,et al.  Fetal Tracheal Occlusion for Severe Pulmonary Hypoplasia in Isolated Congenital Diaphragmatic Hernia: A Systematic Review and Meta-analysis of Survival , 2016, Annals of surgery.

[9]  D. Black,et al.  Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. , 2016, The Journal of pediatrics.

[10]  C. Nardiello,et al.  MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality , 2016, Molecular and Cellular Pediatrics.

[11]  D. Seliktar,et al.  Hydrogels for therapeutic cardiovascular angiogenesis. , 2016, Advanced drug delivery reviews.

[12]  C. Morley,et al.  Oxygen Saturation Targeting and Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.

[13]  Sharon Gerecht,et al.  Acellular implantable and injectable hydrogels for vascular regeneration , 2015, Biomedical materials.

[14]  A. Millar,et al.  Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis. , 2014, QJM : monthly journal of the Association of Physicians.

[15]  E. Morrisey,et al.  Lung development: orchestrating the generation and regeneration of a complex organ , 2014, Development.

[16]  Ralph Müller,et al.  Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing , 2011, Science Translational Medicine.

[17]  N. Voelkel,et al.  COPD/emphysema: The vascular story , 2011, Pulmonary circulation.

[18]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[19]  Y. Tabata,et al.  Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension. , 2008, The Journal of thoracic and cardiovascular surgery.

[20]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[21]  J. Greer,et al.  Congenital diaphragmatic hernia, tracheal occlusion, thyroid transcription factor-1, and fetal pulmonary epithelial maturation. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[22]  T. Godfrey,et al.  Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. , 2004, Clinical chemistry.

[23]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[24]  Elliot L Chaikof,et al.  Biomaterials for vascular tissue engineering. , 2010, Regenerative medicine.